397 related articles for article (PubMed ID: 1692606)
1. Sialic acid residues as catalysts for M2-muscarinic agonist-receptor interactions.
Haddad EB; Landry Y; Gies JP
Mol Pharmacol; 1990 May; 37(5):682-8. PubMed ID: 1692606
[TBL] [Abstract][Full Text] [Related]
2. Regional distribution of M1, M2 and non-M1, non-M2 subtypes of muscarinic binding sites in rat brain.
Ehlert FJ; Tran LP
J Pharmacol Exp Ther; 1990 Dec; 255(3):1148-57. PubMed ID: 2262898
[TBL] [Abstract][Full Text] [Related]
3. Sialic acid is selectively involved in the interaction of agonists with M2 muscarinic acetylcholine receptors.
Gies JP; Landry Y
Biochem Biophys Res Commun; 1988 Jan; 150(2):673-80. PubMed ID: 3342042
[TBL] [Abstract][Full Text] [Related]
4. [3H]pirenzepine and (-)-[3H]quinuclidinyl benzilate binding to rat cerebral cortical and cardiac muscarinic cholinergic sites. I. Characterization and regulation of agonist binding to putative muscarinic subtypes.
Watson M; Yamamura HI; Roeske WR
J Pharmacol Exp Ther; 1986 May; 237(2):411-8. PubMed ID: 3754580
[TBL] [Abstract][Full Text] [Related]
5. [3H]pirenzepine and (-)-[3H]quinuclidinyl benzilate binding to rat cerebral cortical and cardiac muscarinic cholinergic sites. II. Characterization and regulation of antagonist binding to putative muscarinic subtypes.
Watson M; Roeske WR; Yamamura HI
J Pharmacol Exp Ther; 1986 May; 237(2):419-27. PubMed ID: 3754581
[TBL] [Abstract][Full Text] [Related]
6. Muscarinic receptor heterogeneity in rat central nervous system. II. Brain receptors labeled by [3H]oxotremorine-M correspond to heterogeneous M2 receptors with very high affinity for agonists.
Gillard M; Waelbroeck M; Christophe J
Mol Pharmacol; 1987 Jul; 32(1):100-8. PubMed ID: 3600611
[TBL] [Abstract][Full Text] [Related]
7. Characterization of the subtype of muscarinic receptor coupled to the stimulation of phosphoinositide hydrolysis in 132-1N1 human astrocytoma cells.
Stephan CC; Sastry BV
Cell Mol Biol (Noisy-le-grand); 1992 Nov; 38(7):701-12. PubMed ID: 1282058
[TBL] [Abstract][Full Text] [Related]
8. Muscarinic M1 receptor agonist actions of muscarinic receptor agonists in rabbit vas deferens.
Shannon HE; Sawyer BD; Bemis KG; Bymaster FP; Health I; Mitch CH; Ward JS
Eur J Pharmacol; 1993 Feb; 232(1):47-57. PubMed ID: 8458395
[TBL] [Abstract][Full Text] [Related]
9. Muscarinic receptor subtypes and sexual behavior in female rats.
Dohanich GP; McMullan DM; Cada DA; Mangum KA
Pharmacol Biochem Behav; 1991 Jan; 38(1):115-24. PubMed ID: 1708147
[TBL] [Abstract][Full Text] [Related]
10. Affinities of muscarinic drugs for [3H]N-methylscopolamine (NMS) and [3H]oxotremorine (OXO) binding to a mixture of M1-M4 muscarinic receptors: use of NMS/OXO-M ratios to group compounds into potential agonist, partial agonist, and antagonist classes.
Sharif NA; Williams GW; DeSantis LM
Neurochem Res; 1995 Jun; 20(6):669-74. PubMed ID: 7566362
[TBL] [Abstract][Full Text] [Related]
11. The interaction of McN-A-343 with muscarine receptors in cardiac and smooth muscle.
Elnatan A; Mitchelson F
Biochem Pharmacol; 1993 Sep; 46(6):993-1003. PubMed ID: 7692853
[TBL] [Abstract][Full Text] [Related]
12. Rat hippocampal muscarinic autoreceptors are similar to the M2 (cardiac) subtype: comparison with hippocampal M1, atrial M2 and ileal M3 receptors.
Richards MH
Br J Pharmacol; 1990 Apr; 99(4):753-61. PubMed ID: 1694463
[TBL] [Abstract][Full Text] [Related]
13. Characterization of [3H]pirenzepine binding to muscarinic cholinergic receptors solubilized from rat brain.
Luthin GR; Wolfe BB
J Pharmacol Exp Ther; 1985 Jul; 234(1):37-44. PubMed ID: 3839265
[TBL] [Abstract][Full Text] [Related]
14. The biphasic response of muscarinic cholinergic receptors in cultured heart cells to agonists. Effects on receptor number and affinity in intact cells and homogenates.
Galper JB; Dziekan LC; O'Hara DS; Smith TW
J Biol Chem; 1982 Sep; 257(17):10344-56. PubMed ID: 7107608
[TBL] [Abstract][Full Text] [Related]
15. Modulation of muscarinic cholinergic receptor affinity for antagonists in rat heart.
Martin MW; Smith MM; Harden TK
J Pharmacol Exp Ther; 1984 Aug; 230(2):424-30. PubMed ID: 6379149
[TBL] [Abstract][Full Text] [Related]
16. Multiple in vitro interactions with and differential in vivo regulation of muscarinic receptor subtypes by tetrahydroaminoacridine.
Flynn DD; Mash DC
J Pharmacol Exp Ther; 1989 Aug; 250(2):573-81. PubMed ID: 2760841
[TBL] [Abstract][Full Text] [Related]
17. Irreversible binding of acetylethylcholine mustard to cardiac cholinergic muscarinic receptors.
Baker SP; Posner P
Mol Pharmacol; 1986 Nov; 30(5):411-8. PubMed ID: 3773882
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological characterization of the M1 muscarinic receptors expressed in murine fibroblast B82 cells.
Mei L; Lai J; Roeske WR; Fraser CM; Venter JC; Yamamura HI
J Pharmacol Exp Ther; 1989 Feb; 248(2):661-70. PubMed ID: 2537406
[TBL] [Abstract][Full Text] [Related]
19. Irreversible and quaternary muscarinic antagonists discriminate multiple muscarinic receptor binding sites in rat brain.
Norman AB; Eubanks JH; Creese I
J Pharmacol Exp Ther; 1989 Mar; 248(3):1116-22. PubMed ID: 2703964
[TBL] [Abstract][Full Text] [Related]
20. A minority of muscarinic receptors mediate rabbit tracheal smooth muscle contraction.
Mahesh VK; Nunan LM; Halonen M; Yamamura HI; Palmer JD; Bloom JW
Am J Respir Cell Mol Biol; 1992 Mar; 6(3):279-86. PubMed ID: 1540392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
